SUBSCRIBE TO BJMO ONCOTALKS SERIES

All podcasts

 

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium
 

Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients

Prof. Dr. Christopher Hoeller, Medical University of Vienna, Vienna, Austria
 

Prof. Dr. Marc Van den Eynde about the results of the PRECONNECT study

Prof. dr. Marc Van den Eynde, digestive oncologist at the Clinique Universitaires Saint-Luc in Brussels
 

Prof. dr. Eric Van Cutsem about the gastro-intestinal highlights from ASCO 2021

Prof. Eric Van Cutsem, head of the digestive oncology department, University Hospitals Leuven
 

Professor Alexander Eggermont about the potential of Bempegaldesleukin combined with nivolumab as adjuvant treatment

Prof. Alexander Eggermont, Chief Scientific Officer, Princess Máxima Centre, Utrecht, The Netherlands
 

Professor Karl Lewis about cemiplimab in patients with metastatic basal cell carcinoma

Prof. Karl Lewis, Medical Oncology, University of Colorado Hospital, Aurora, CO, USA
 

Prof. dr. Sylvie Rottey

Prof. dr. Sylvie Rottey discusses the updated BSMO guidelines